Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Benitec Biopharma Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 25 | 21 | −4 |
| Shares | 12.3M | 11.6M | −674.5K (−5.5%) |
| Value | $2.09M | $2.44M | +$351.8K (+16.8%) |
New holders (1)
Institutions that held Benitec Biopharma Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Private Advisor Group, LLC | 13,157 | $2.76K | 0.00% |
Sold out (5)
Institutions that held Benitec Biopharma Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 55,078 | $9.36K |
| Jane Street Group, LLC | 27,475 | $4.67K |
| Two Sigma Advisers, LP | 23,200 | $3.94K |
| HRT Financial LP | 11,481 | $1.00K |
| Rockefeller Capital Management L.P. | 300 | $0 |